PRNewsWire - Health

Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop® for US market approval
Accord Healthcare reçoit l'approbation de la Medicines and Healthcare Regulatory Agency (MHRA) pour Hetronifly® (Serplulimab), pour le traitement de première ligne du cancer du poumon à petites cellules au stade extensif (ES-SCLC).
Nippon Shokubai Plans to Expand Its GMP-compliant Nucleic Acid Drug API Manufacturing Capacity Tenfold
Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year